Ignite Creation Date:
2025-12-24 @ 5:15 PM
Ignite Modification Date:
2026-01-14 @ 2:57 PM
Study NCT ID:
NCT00237250
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2005-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2006-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-09
First Submit QC Date:
None
Study First Post Date:
2005-10-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-04
Last Update Post Date:
2012-05-07
Last Update Post Date Type:
ESTIMATED